Standard Panels
9 Panel Standard
Summary
A 9-panel lab screen adding methadone and propoxyphene to the 7-panel coverage.
Why it matters
A lab-based urine screen with confirmation testing. Positive screens are confirmed before reporting, giving results suitable for employment and clinical use.
What this panel screens for
9 substances included in this panel.
Amphetamines (AMP)
Stimulants including amphetamine and prescription drugs like Adderall.
Cutoff: 1000 ng/mL
Barbiturates (BAR)
Sedative drugs such as phenobarbital.
Cutoff: 300 ng/mL
Cocaine (COC)
Cocaine and its primary metabolite.
Cutoff: 300 ng/mL
Benzodiazepines (BZO)
Sedatives such as Xanax, Valium, and Ativan.
Cutoff: 300 ng/mL
Methadone (MTD)
A long-acting opioid used for pain and addiction treatment.
Cutoff: 300 ng/mL
Extended Opiates (4)
Morphine, codeine, hydrocodone, and hydromorphone — broader than a standard opiate screen.
Cutoff: 2000 ng/mL
Phencyclidine (PCP)
PCP, a dissociative drug also known as 'angel dust.'
Cutoff: 25 ng/mL
Propoxyphene (PHN)
A prescription opioid pain reliever (Darvon).
Cutoff: 300 ng/mL
Marijuana (THC)
The active compound in cannabis.
Cutoff: 50 ng/mL
All amphetamine positives include D/L methamphetamine isomer testing. Cutoffs shown are screening levels.